Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury
SCIPHS
Passive Heating as an Accessible and Tolerable Strategy to Improve the Inflammatory Profile and Cardiometabolic Health in People With Spinal Cord Injury
1 other identifier
interventional
10
1 country
1
Brief Summary
SCI results in higher incidence of heart disease and diabetes and heart disease is the most common cause of death. Chronic inflammation, deleterious changes in vascular structure and impaired glucose metabolism are risk factors that contribute to both heart disease and diabetes. While exercise can help reduce these risk factors, paralysis and impaired accessibility often precludes exercise in persons with SCI. New research in able-bodied persons demonstrates passive heating decreases inflammation and improves vascular function. Similar studies in persons with SCI suggest they may also have the same health benefits however these studies only investigated the impact of short term (one episode) passive heating (as opposed to repeated bouts). Repeated bouts of heat exposure will likely be required to impact chronic inflammation, but this has never been tested in persons with SCI. This study will test the impact of repeated bouts (3x/week) of passive heat stress over a longer term (8 weeks) on inflammation, metabolism and vascular function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2021
CompletedFirst Posted
Study publicly available on registry
July 21, 2021
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedResults Posted
Study results publicly available
March 6, 2026
CompletedMarch 6, 2026
February 1, 2026
2 years
July 9, 2021
July 25, 2025
February 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Interleukin-6
Plasma concentration, which was determined using enzyme-linked immunosorbent assays.
change from 0 weeks to 8 weeks to 16 weeks
Secondary Outcomes (4)
Maximal Cutaneous Vascular Conductance
change from 0 weeks to 8 weeks to 16 weeks
Glucose Tolerance
change from 0 to 8 to 16 weeks
TNF-alpha
change from 0 to 8 to 16 weeks
Interleukin-1ra
change from 0 to 8 to 16 weeks
Other Outcomes (3)
5-item Mental Health Inventory
change from 0 to 8 to 16 weeks
SCI Chronic Pain Survey
change from 0 weeks to 8 weeks to 16 weeks
Daytime Sleepiness
change from 0 to 8 to 16 weeks
Study Arms (2)
Control
OTHERPassive heat stress x1 visit then no intervention for 8 weeks. Participants continue regular exercise habits as usual.
Passive heat stress
EXPERIMENTALAfter arm 1, passive heat stress 3x/week x8 weeks.
Interventions
After arm 1, passive heat stress 3x/week x8 weeks.
Eligibility Criteria
You may qualify if:
- Stable SCI over 1 year of duration
You may not qualify if:
- Persons who smoke cigarettes
- Daily administration of anti-inflammatory medications
- Daily administration of vasoactive medications
- Pressure ulcer stage 3 or 4
- History of heat related illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
South Texas Health Care System, San Antonio, TX
San Antonio, Texas, 78229-4404, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Aside from the small sample size, the generalizability of the results is limited by the inclusion of Veterans only. Veterans likely have different experiences with mental health, sleep, and pain compared to non-veterans. Follow-up studies should include a control group, preferably one that undergoes a sham-control intervention. Lastly, the investigators did not account for medication use during the study period, such as those that may impact mental health, sleep, or pain.
Results Point of Contact
- Title
- Dr. Michelle Trbovich, MD
- Organization
- South Texas Veteran's Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Michelle B Trbovich, MD
South Texas Health Care System, San Antonio, TX
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2021
First Posted
July 21, 2021
Study Start
July 1, 2022
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
March 6, 2026
Results First Posted
March 6, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share